Search
forResearch 10 of 1000+
- Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Adverse Effects and Drug Interactions of Biologic Agents
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review
- Denosumab-induced alopecia areata with lichenoid eruption
- New Modalities in the Treatment of Refractory Alopecia Areata
Community 2 of 4
- Why hasn’t anyone made a "DHT sponge" biologic yet???
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
Learn
— no results
Try a deeper search in learn →